About Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.
Founded
1995
CEO
Ravichandran Chitra
Employees
339
HQ
Chennai, Tamil Nadu
Finished Products
1Revenue from Operations
₹150.94Cr2Export Sales
₹72.98Cr3Domestic Sales
₹72.03Cr4Other Operating Revenue
₹1.53Cr5Analytical Income
₹0.84CrRaw Materials
1Raw Material Consumed
₹153.50Cr2Purchase of stock in Trade
₹12.57CrAbout Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.
Founded:1995
CEO:Ravichandran Chitra
Employees:339
HQ:Chennai, Tamil Nadu
Finished Products
1Revenue from Operations
₹150.94Cr2Export Sales
₹72.98Cr3Domestic Sales
₹72.03Cr4Other Operating Revenue
₹1.53Cr5Analytical Income
₹0.84CrRaw Materials
1Raw Material Consumed
₹153.50Cr2Purchase of stock in Trade
₹12.57CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹319
52W Low
₹95
Volume7.53K
Avg VolumeN/A
Beta0.27
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
95.74x
Valuation
P/B Ratio
7.75x
Valuation
EPS
₹3.29
Valuation
Dividend Yield
0.00%
Valuation
ROE
11.54%
Profitability
ROCE
10.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and trading of pharmaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
63.8%
International
36.2%
INDIA63.8%
ASIA21.8%
UK12.1%
AFRICA2.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.39x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-3.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.